Market News AIOpen the app

Integra LifeSciences is changing its 2026 plans because of damage from flooding.

ResultsRead the original at Benzinga
Bad for IART

IART expects flood damage to cut fourth-quarter sales by $15 million to $20 million and lowered its 2026 sales and profit forecasts. Insurance should cover much of the financial harm, but lost sales and a long repair period leave its outlook weaker.

IART · Integra LifeSciences Holdings Corporation

AI read · Bad for IART

The AI's read

Fewer products from the Cincinnati plant can reach customers, and IART expects sales losses to grow in the fourth quarter. Full production is not expected until the second quarter of 2027. Insurance should cover much of the financial harm over time. It does not restore lost sales, and the company also lowered its expected 2026 sales and profit.

Get alerts for IART

Follow Integra LifeSciences Holdings Corporation (IART) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IART
Free on the App Store and Google Play, or on the web.